Coverage
-
June 02, 2014
Mylan Pharmaceuticals Inc. has reached a deal with Pfizer Inc. to allow it to begin selling generic versions of arthritis drug Celebrex by the end of the year, Mylan said in a statement Monday.
2 other articles on this case.
View all »